US Patent Issued to Tolmar International on Oct. 28 for "Leuprolide acetate compositions and methods of using the same to treat breast cancer" (Colorado Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,754, issued on Oct. 28, was assigned to Tolmar International Ltd. (Dublin).

"Leuprolide acetate compositions and methods of using the same to treat breast cancer" was invented by John Middleton (Fort Collins, Colo.), Avinash Nangia (Fort Collins, Colo.), John Arthur Mclane (Loveland, Colo.) and Terri L. Morton (Loveland, Colo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods for suppressing ovarian function in subjects with hormone receptor-positive breast cancer."

The patent was filed on May 26, 2020, under Application No. 17/614,312.

*For further information, including images, charts and tables, please visit: http://patft....